drugset / Trial / NCT01885715

Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium

NCT01885715

Completed 112 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to find appropriate dose of neostigmine which is possible to reverse rocuronium or cisatracurium till train of four (TOF) 0.9 within 10 minutes.

Timeline

Start
2013-06
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 10 ug/kg Other
Comparator Neostigmine Other / unclassified 20 ug/kg Other
Comparator Neostigmine Other / unclassified 40 ug/kg Other

Indications

No indication recorded.